The contribution of peptides to T cell allorecognition and allograft rejection

International Reviews of Immunology

Volumn 13, Issue 3, 1996, Pages 231-243

  Benichou, Gilles ^a   Fedoseyeva, Eugenia V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunodominance; MHC peptides; T cells; Transplantation

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; PEPTIDE;

ALLOTRANSPLANTATION; ANIMAL; ANTIGEN PRESENTATION; BAGG ALBINO MOUSE; CHEMISTRY; GENETICS; GRAFT REJECTION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MOUSE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; EPITOPES, T-LYMPHOCYTE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; PEPTIDES; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029691231     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.3109/08830189609061750     Document Type: Article

References (60)

1. Townsend, A. R. M., Rothbard, J., Gotch, F. M., Bamadur, G., Wraith, D., and McMichael, A. J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44, 959, 1986.
2. Babbit, B. P., Allen, P. M., Matsueda, G., Haber, E. P , and Unanue, E. R. Binding of immunogenic peptides to a la histocompatibility molecule. Nature 317, 359, 1985.
3. Snell, G. D. Studies in histocompatibility. Science 213, 172, 1981.
4. Dausset, J. The major histocompatibitity complex in man. Science 213, 1469, 1981.
5. Fischer, L. K. and Wilson, D. B. Histocompatibility antigen-activated cytotoxic T lymphocytes. Estimates of the frequency and specificity of precursors. J. Exp. Med. 145, 508, 1977.
6. Matzinger, P. and Bevan, M. J. Hypothesis, why do so many lymphocytes respond to major histocompatibility antigens. Cell Immunol. 29, 1, 1977.
7. Lombardi, G., Sidhu, S., Batchelor, J. R., and Lechler, R. I Allorecognition of DR1 by T cells from a DR4/ DRw13 responder mimic self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA 86, 4190, 1989.
8. Lombardi, G., Sidhu, S., Lamb, J. R., Batchelor, J. R., and Lechler, R. I. Co-recognition of endogenous antigens with HLA-DR1 by alloreactive T cell clones. J. Immunol. 142, 753, 1989.
9. Lechler, R. I., Heaton, T., Barber, L., Ball, V., Batchelor, J. R., and Lombardi, G. Molecular mimicry by major histocompatibuity complex molecules and peptides accounts for some alloresponses. Immunol. Lett. 34, 63, 1992.
10. Heath, W. R. and Sherman, L. A. Cell type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: consequence of peptide-dependent allorecognition. Eur. J. Immunol. 21, 153, 1990.
11. Heath, W. R., Hurd, M. E., Carbone, F. R., and Sherman, L. A. Peptides dependent recognition of H-2K by alloreactive cytotoxic T lymphocytes. Nature 341, 749, 1989.
12. Heath, W. R., Kane, K. P., Mescher, M. F., and Sherman, L. A. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 88, 5101, 1991.
13. Chicz, R. M., Urban, R. G., and Lane, W. S. Predominant naturally processed peptides bound to HLA-DR1 and derived from MHC related molecules and are heterogeneous in size. Nature 258, 764, 1992.
14. van Rood, J. J., van Leeuwen, A., and Santen, M. C. T. Anti-HLA-A2 inhibitor in normal serum. Nature 226, 366, 1970.
15. Charlton, R. N. and Zmijewski, C. M. Soluble HLA-A7 antigen: localization in the liipoprotein fraction of human serum. Science 170, 636, 1970.
16. Sherwood, R. A., Brent, L., and Rayfield, L. S. Presentation of alloantigens by host cells. Eur. J. Immunol. 16, 569, 1986.
17. Maryanski, J. L., Pola, P. Corradin, G., Jordan, B. R., and Cerottini, J. C. H-2 restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature 324, 578, 1986.
18. Olson, C. A., Williams, L. C., McLaughlin-Taylor, E., and McMillan, M. Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 86, 1031, 1989.
19. Song, E. S., Linsk, R., Olson, C. A., McMillan, M., and Goodenow, R. S Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. Proc. Natl. Acad. Sci. USA 85, 1927, 1988.
20. Chen, P. B., Madrigal, A., and Parham, P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp Med. 172, 779, 1990.
21. + alloreactive T lymphocyte clone. J. Exp. Med. 172, 387, 1990.
22. Benichou, G., Takizawa, A. P., Olson, A. C., McMillan, M., and Sercarz, E. E Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med. 175, 305-308, 1992.
23. + cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation 60, 1621, 1995.
24. Fangmann, J., Dalchau, R., Sawyer, G. J., Priestly, C. A., and Fabre, J. W. T cell recognition of donor major histocompatibility complex class I peptsdes during allograft rejection. Eur J. Immunol. 22, 1525, 1992.
25. Liu, Z., Braunstein, N. S., and Suciu-Foca, N. T cell recognition of allopeptides in context of syngeneic MHC. J. Immunol. 148, 35, 1992.
26. Benichou, G., Fedoseyeva. E., Lehmann, P. V., Olson, C. A., Geysen, H. M., McMillan, M., and Sercarz, E. E. Limited T cell response to donor MHC peptides during allograft rejection. Implication for selective immune therapy in transplantation. J. Immunol. 153, 938, 1994.
27. Liu, Z., Sun, Y. K., and Xi, Y. P. Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J. Immunol. 150, 3180, 1993.
28. Ashwell, J. D., Chen, C , and Schwartz, R. H. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J. Immunol. 169, 115, 1989.
29. Bill, J., Yague, J , Appel, V. B., White, J., Horn, G., Erlich, H A., and Palmer, E. Molecular genetic analysis of 178 1-A bm-12-reactive T cells. J. Exp. Med. 169, 115, 1989.
30. Sawyer, G. J., Dalchau, R., and Fabre, J. W. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant Immunol. 1, 77, 1993.
31. Hayry, P., VonWillebrand, E., Partehnais, E., Nemlander, A., Soots, A., Lautenschlager, I., Alfoldy, P., and Renkonen, R. The inflammatory mechanisms of allograft rejection. Immunol. Rev. 2, 1115, 1983.
32. Botazzo, G. F., Pujol-Borrell, R., and Hanafusa, T. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2, 1115, 1983.
33. Lo, D., Burkly, L. C., Flavell, R. A., Palmiter, R. D., and Brinster, R. L. Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells J. Exp. Med. 170, 87, 1989.
34. Gaspari, A. A , Jenkins, M. K., and Katz, S. I. Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific TH1 clones. J. Immunol. 7, 2216, 1988.
35. Shoskes, D. A. and Wood, K. J. Indirect presentation of MHC antigens in transplantation. Immunol. Today 15, 32, 1994.
36. Sercarz, E. E., Lehmann, P. V., Ametani, A., Benichou, G., Miller, A., and Moudgil, K. Dominance and crypticity of T cell antigenic determinants. Ann. Rev. Immunol. 11, 729, 1993.
37. Lipham W. J., Redmond, T. M., Takahashi, H., Berzofsky, J. A., Wiggert, B., Chader, G. J., and Gery, I. Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune process. J. Immunol. 146, 3757, 1991.
38. Lehmann, P. V., Forsthuber, T., Miller, A., and Sercarz, E. E. Spreading of T cell autoimmunity to cryptic determinants of autoantigen. Nature 358, 155, 1992.
39. Vidard, L., Rock, K. R., and Benacerraf, B. Heterogeneity in antigen processing by different types of antigen-presenting cells. J. Immunol. 149, 1905, 1992.
40. Loss, G. E., Elias, C. G., Fields, P. E., Ribaudo, R. K., McKisic, M., and Sant, A. J. Major histocompatibility complex class II restricted presentation of an internally synthesized antigen displays cell-type variability and segresates from the exogenous class II and endogenous class I presentation pathways. J. Exp. Med. 178, 73, 1993.
41. Benichou, G., Fedoseyeva, E., Olson, C. A., Geysen, H. M., McMillan, M., and Sercarz, E. E. Disruption of the determinant hierarchy on a self-MHC peptide: concomitant tolerance induction to the dominant determinant and priming to the cryptic self-determinant. Intl. Immunol. 6, 131, 1994.
42. Brown, M. G., Driscoll, J., and Monaco, J. J. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature 353, 355, 1991.
43. Glynne, R., Powis, S. H., Beck, S., Keely, A., Kerr, A., Kerr, L., and Trowsdale, J. A proteosome-related gene between the two ABC transporter loca in the class II region of the human MHC. Nature 353, 357, 1991.
44. Monaco, J. J., Cho, S., and Attaya, M. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 250, 1723, 1990.
45. Deverson, E. V., Gow, I. R., Coadwell, W. J., Monaco, J. J., Butcher, G W., and Howard, J. C. MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters. Nature 348, 738, 1990.
46. Spies, T., Bresnahan, M., Bahram, S., Arnold, D., Blanck, G., Mellins, E., Pious, D., and DeMars, R. A gene in the human major histocompatibility complex class II region controlling the class I antigen processing pathway. Nature 348, 744, 1990.
47. Bodmer, H., Viville, S., Benoist, C , and Mathis, D. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263, 1284, 1994.
48. Vanbuskirk, A., Crump, B. L., Margoliash, E., and Pierce, S. K. A peptide binding protein having a role in antigen presentation is a member of the hsp70 heat shock family. J. Exp. Med. 170, 1799, 1989.
49. Fling, S. P., Arp, B., and Pious, D. HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells. Nature 368, 554, 1994.
50. Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J. J., and Mellins, E. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551, 1994.
51. Benichou, G., Takizawa, P. A., Ho, P. T., Killiow, C. C., Olson, C. A , McMillan, M., and Sercarz, E. E. Immunogenicity and tolerogenicity of self-MHC peptides. J. Exp. Med. 172, 1341, 1990.
52. - T cells is governed by a processing factor which maps to the class II region of the major histocompatibility complex locus. J. Exp. Med. 182, 1481, 1995.
53. Kaufman, D. L., Clare-Salzer, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J., and Lehmann, P. V Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine-dependent diabetes. Nature 366, 72, 1993.
54. McRae, B. L., Vanderlugt, C. L., Dal Canto, M C., and Miller, S. D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182, 75, 1995.
55. Fedoseyeva, E. V., Tam, R. C , Popov, I. A., Orr, P. L., Garovoy, M. R., and Benichou, G. Induction of T cell responses to a self-antigen following allotransplantation. Transplantation, 1995, in press.
56. Sloan-Lancaster, J. and Allen, P. M. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Current Top. Immunol. 7, 103, 1995.
57. Parham, P., Clayberger, C., Zorn, S. L., Ludwig, D. S., Schoolnik, G. K., and Krensky, A. M. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha-2 domain of HLA-A2. Nature 325, 625, 1987.
58. Clayberger, C., Parham, P., Rothbard, J., Ludwig, D. S., Schoolnik, G. K., and Krensky, A. M. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature 330, 763, 1987.
59. Sayegh, M. H., Khoury, S. K., Hancock, W. W., Weiner, H. L. and Carpenter, C. B. Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc. Natl. Acad. Sci. USA 89, 7762, 1992.
60. Sayegh, M. H., Perico, N., Imberti, O., Hancock, W. W., Carpenter, C. B., and Remuzzi, G. Thymic recognition of class II MHC allopeptides induces donor specific unresponsiveness to renal allografts. Transplantation 56, 461, 1993